- Rating
- 2
- Confidence
- 4
- Informativeness
- 2
- Presentation
- 2
- Soundness
- 3
Read review
Paper summary
This paper proposes KineWorld, a latent kinetic world modeling framework for synthesizing DCE-MRI sequences from pre-contrast scans. It combines pharmacokinetics-inspired latent rollout, kinetics-aware retrieval, and relay-guarded training to model temporal enhancement dynamics while preserving anatomical consistency. Experiments on three DCE-MRI datasets compare the method with image-to-image and video generation baselines in terms of image quality and kinetic fidelity, along with ablation studies and a radiologist reader study.
Critical strengths
- The paper focuses on a clinically meaningful problem of synthesizing DCE-MRI sequences from pre-contrast scans, with an emphasis on anatomical consistency and temporal enhancement dynamics.
- The method is evaluated on three datasets against multiple image-to-image and video generation baselines, with reported improvements in image quality and kinetic fidelity. Additional ablation studies and a radiologist reader study provide further empirical evidence.
Critical weaknesses
- The proposed framework lacks explicit action-conditioned dynamics or controllable interventions. Although temporal embeddings are incorporated, time serves as a temporal coordinate rather than an action that controls how the underlying system evolves. Therefore, the justification for characterizing KineWorld as a world model remains insufficient.
- KineWorld essentially performs autoregressive latent state prediction conditioned on historical states and timestamps. The paper does not establish what fundamental modeling capabilities, as a world model, distinguish this approach from conventional time-conditioned video prediction.
- The proposed influx and efflux terms are learned in an unconstrained latent space and do not correspond to measurable pharmacokinetic quantities. As acknowledged in Appendix A.1, their relationship to the Tofts model is structural rather than physical. It remains unclear whether the proposed formulation genuinely captures pharmacokinetic mechanisms or simply introduces a flexible parameterization of latent state transitions.
- The paper claims to support state prediction at arbitrary timestamps through dense temporal rollout. However, quantitative evaluations are primarily performed at observed acquisition timestamps. Experiments on held-out intermediate timestamps are needed to verify whether the model learns continuous-time dynamics rather than fitting the observed temporal sequence.
- The reported PSNR, SSIM, and LPIPS primarily measure reconstruction agreement with reference images rather than directly quantifying anatomical stability across generated frames. More explicit evaluations of lesion morphology preservation and temporal structural drift would better support the claimed anatomical consistency.
- Although KineWorld uses physical-time embeddings and integrates latent velocities on a one-second temporal grid, this does not by itself establish a consistent continuous-time dynamical model. The learned transitions are supervised primarily at sparsely observed acquisition timestamps, and the paper does not demonstrate whether the predicted state at a given physical time remains consistent under different integration step sizes or rollout discretizations. Therefore, the claimed continuous-time modeling capability requires stronger justification.
Questions for authors
- What fundamentally distinguishes KineWorld from conventional time-conditioned autoregressive video prediction? Without explicit action-conditioned dynamics or controllable interventions, what specific capabilities justify its characterization as a world model?
- How can the authors justify that the learned influx–efflux decomposition captures meaningful pharmacokinetic dynamics rather than an arbitrary parameterization of latent state transitions? Would a generic latent residual predictor achieve comparable performance?
- Can the authors provide evaluations at held-out intermediate timestamps and analyze the sensitivity to different integration step sizes? These experiments would help clarify whether KineWorld learns consistent continuous-time dynamics rather than simply reproducing observed temporal sequences.
5 comments
W1 & W2 & Q1: Definition of the world model terminology
Following CEK-World [1], we formulate contrast-free DCE-MRI synthesis as world modeling of contrast-enhancement kinetics. Contrast-agent injection is the initiating action in the underlying medical process. Unlike autonomous driving involving dense control actions, our task focuses on long-horizon, patient-conditioned latent evolution following a single injection. This shares the predictive representation spirits with V-JEPA 2’s action-free training, learning representations of the world intrinsic structure and dynamics does not require action inputs at every transition.[2]
In our setting, the core regularities are the stability of patient-specific anatomy and the temporal evolution of tissue-specific enhancement dynamics. KineWorld aims to represent both in latent space. To guide the representation learning, we translate these regularities into two core modeling targets, (i) anatomical consistency, keeping anatomy spatially and morphologically stable, (ii) kinetic fidelity, reproducing the temporally ordered enhancement evolution among wash-in, peak-enhancement, and wash-out phases.
[1] Kong, J., et al. ‘MRI contrast enhancement kinetics world model.’ CVPR 2026.
[2] Assran, M, et al. ‘V-JEPA 2: Self-Supervised Video Models Enable Understanding, Prediction and Planning.’ Meta AI tech report, 2025.
W3 & Q2: What the pharmacokinetic (PK) connection establishes
To achieve these, in contrast to conventional video generation, we design Tofts function inspired PK-Roll module to explicitly modulaet contrast agent velocities over a fixed pre-contrast anatomy. The connection to the Tofts model is structural rather than quantitative. The learned influx and efflux terms are not estimates of measurable concentrations or transfer constants. Our claim is that this structure provides an explicit modeling strategy for learning enhancement kinetics within a latent world-model framework, rather than estimating physical PK parameters.
To test whether this Tofts-inspired structure design offers benefits beyond a generic learned transition, we distinguish two comparisons. (i) Retrained generic-velocity predictor. We remove the efflux term and retrain the remaining predictor while retaining the influx Transformer. This tests whether directly learning the latent velocity achieves comparable performance without the structured damping term. (ii) Efflux disabled after full-model training. We set only during inference using the fully trained model. These comparisons assess the predictive benefit of the proposed Tofts-inspired structure. The results are updated in Sec. 3.4.
| Duke | ProstateX | |||||||
|---|---|---|---|---|---|---|---|---|
| SSIM | PSNR | CCC | S-MAE | SSIM | PSNR | CCC | S-MAE | |
| Directly learning velocity | 0.7448 | 24.66 | 0.7340 | 88.93 | 0.8282 | 24.71 | 0.8416 | 69.85 |
| 0.7413 | 24.32 | 0.7502 | 70.47 | 0.8251 | 24.68 | 0.8845 | 45.76 | |
| Ours | 0.7568 | 26.06 | 0.8015 | 57.89 | 0.8440 | 26.10 | 0.9412 | 25.44 |
Thank you for the insightful questions. To our best understanding, world modeling aims to learn a system’s underlying dynamics and does not necessarily require dense action inputs. In DCE-MRI, these dynamics concern contrast-enhancement pharmacokinetics (PK), motivating our PK-inspired latent representation transition design. In our method, time serves as a coordinate, not a separately learned time-advance action: every queried state follows the same sequence of 1-second PK-Roll updates with its kinetic history retained. This design avoids query-dependent inconsistencies arising from alternative compositions of time-advance actions on the specified grid. The responses below clarify this rationale and its supporting evidence.